Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial.

Petr JarolímWilliam B WhiteChristopher P CannonQi GaoDavid A Morrow

Published in: Diabetes care (2018)

Serial monitoring of NT-proBNP in patients with type 2 diabetes and ischemic heart disease may be useful for identifying patients at highest risk for HF.

Keyphrases

study protocol
phase iii
clinical trial
phase ii
ejection fraction
acute heart failure